NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Fangzhou Inc.

Fangzhou Inc.

Public
Haidian, BeijingConsumer Products and Services (B2C)https://www.jianke.com/

Fangzhou Inc. is now publicly traded

The data on this page reflects Fangzhou Inc.'s private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Went Public

Jul 9, 2024

Last Round

Series D

Extension

Jan 1, 2023

Est. Valuation at Exit

$1.4B

Total Funding Raised

$366.5M

Company Overview

Fangzhou Inc., operating through its platform Jianke, is a leading online platform for chronic disease management in China. The company provides comprehensive medical services, including follow-up physician consultations and e-prescriptions, alongside online retail pharmacy services. It focuses primarily on patients with chronic conditions such as hypertension, cardiovascular diseases, and respiratory diseases. The platform connects a large base of registered users and doctors, and also offers customized content and marketing solutions to pharmaceutical companies. The company is publicly traded on the Hong Kong Stock Exchange under the ticker 06086.

Sector

Consumer Products and Services (B2C)

AI Layer

Non-AI

Keywords

online chronic disease management platform'Hospital to Home' (H2H) service modelonline retail pharmacy for chronic conditionse-prescription and medication delivery servicefollow-up consultation platform for physiciansdirect-to-consumer healthcare platformtelemedicine for chronic disease patientsintegrated online healthcare platformcustomized marketing for pharmaceutical companieswholesale pharmaceutical distribution

Fangzhou Inc. Comparables

Compare Fangzhou Inc. with similar companies based on industry and business-model similarity.

Fangzhou Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Miaoshou Doctor
83%
Beijing Yuanxin Technology Group Co., Ltd.
83%
WeDoctor
76%

Fangzhou Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
IPOJul 9, 2024
Series D ExtensionJan 1, 2023
Series DMay 1, 2022
Series CDec 31, 2020
Series BSep 4, 2018
Series A Extension
May 14, 2017

Fangzhou Inc. Investors

Notable investors and investment history

Fangzhou Inc. investors
InvestorRounds
HBM Healthcare InvestmentsSeries B
Crescent PointSeries B, Series A
PGA Venture PartnersSeries A Extension
Shenzhen GTJA Investment GroupSeries B
Volcanics VentureSeries A Extension
CitigroupIPO

Fangzhou Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Fangzhou Inc. Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersHaidian, Beijing
Employee Range190
Year Founded2006
Last FundingJan 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.